SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED — Ampicillin Importer Profile
Pharmaceutical Importer · #12 buyer for Ampicillin · $2.5M import value · 98 shipments · TANZANIA · DGFT Verified
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED is the #12 importer of Ampicillin from India with $2.5M in import value and 98 verified shipments. SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED holds a 1.0% market share in Ampicillin imports based in TANZANIA. The company sources from 1 verified supplier across 57 formulations shipped to 1 country.
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED — Ampicillin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ampicillin to SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED?
Verified from 98 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SPARSH BIO-TECH PRIVATE LIMITED | $2.5M | 98 | 100.0% |
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED sources Ampicillin from 1 verified Indian supplier based on 98 customs records. The primary supplier is SPARSH BIO-TECH PRIVATE LIMITED accounting for 100.0% of imports.
How Does SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED Compare to Nearest Ampicillin Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | WORLDWIDE COMMERICAL VENTURES LTD | NIGERIA | $2.4M | 48 | $50.0K |
| 7 | AVERROES PHARMACEUTICALSSDN BHD MLY | MALAYSIA | $2.0M | 40 | $50.0K |
| 12 | SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED ★ | TANZANIA | $1.3M | 25 | $50.0K |
| 15 | MYLAN BRASIL DISTRIBUIDORA | BRAZIL | $1.2M | 33 | $36.6K |
| 4 | SBR GROUP OF COMPANIES | LIBERIA | $1.2M | 24 | $50.0K |
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED ranks #12 among 924 Ampicillin importers from India. Average shipment value of $50.0K compared to the market average of $27.7K. The closest competitors by value are WORLDWIDE COMMERICAL VENTURES LTD and AVERROES PHARMACEUTICALSSDN BHD MLY.
Where Does SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED Import Ampicillin To?
Destination countries from 98 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $2.5M | 98 | 100.0% |
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED imports Ampicillin to 1 country. The primary destination is TANZANIA receiving 100.0% of shipments worth $2.5M.
What Ampicillin Formulations Does SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 5529.160 KGS / PRICEPER KG 45.34985 USDPCS | $150.0K | 3 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 6220.305 KGS / PRICEPER KG 42.27405 USDPCS | $150.0K | 3 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG Total Net Weight - 4146.802 kgs / Price Per kg 43.73177 USD | $100.0K | 2 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 4146.870 KGS / PRICEPER KG 45.37901 USD | $100.0K | 2 |
| AMPICILLIN & CLOXACILLIN CAPSULES 500MGTotal Net Weight - 2748.528 kgs / PricePer kg 41.37026 USD | $100.0K | 2 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG Total Net Weight - 4837.054 kgs / Price Per kg 41.37027 USD | $100.0K | 2 |
| AMPICILLIN AND CLOXACILLIN CAPSULES 500MG TOTAL NET WEIGHT - 2073.435 KGS / PRICE PER KG 41.86589 USDPCS | $86.0K | 3 |
| AMPICILLIN & CLOXACILLIN ORAL SUSPENSIONTOTAL NET WEIGHT - 2261.610 KGS / PRICEPER KG 16.47833 USDPCS | $74.0K | 6 |
| AMPICILLIN AND CLOXACILLIN ORAL SUSPENSION BP Total Net Weight - 1808.760 kgs /Price Per kg 16.33333 USD | $60.1K | 2 |
| AMPICILLIN & CLOXACILLIN ORAL SUSPENSIONTOTAL NET WEIGHT - 3618.600 KGS / PRICEPER KG 16.07233 USD | $56.7K | 3 |
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED imports 57 distinct Ampicillin formulations from India. The top formulation is AMPICILLIN & CLOXACILLIN CAPSULES 500 MGTOTAL NET WEIGHT - 5 with 3 shipments worth $150.0K.
Who Are the Top Buyers of Ampicillin from India and How Much Does SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED Import?
India exported $25.6M worth of Ampicillin through 4,470 shipments from 486 suppliers to 133 countries, serving 924 buyers globally. SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED imports $2.5M of this total, accounting for 1.0% of India's Ampicillin exports with 98 shipments from TANZANIA. This is verified from 98 customs shipment records covering 57 distinct formulations.
What Is the Average Order Value for SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED's Ampicillin Imports?
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED's average Ampicillin order value is $25.4K per consignment, based on 98 shipments totaling $2.5M. SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED is based in TANZANIA and ranks #12 among all Ampicillin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ampicillin to SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED?
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED sources Ampicillin from 1 verified Indian supplier: SPARSH BIO-TECH PRIVATE LIMITED ($2.5M, 100.0%). This is based on 98 customs records.
How Does SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED Compare to Other Ampicillin Importers?
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED ranks #12 among 924 Ampicillin importers from India with a 1.0% market share. The top 3 importers are ARMAS PHARMACEUTICALS ($7.3M), AORTA COMPANY LIMITED ($3.7M), SPARSH BIO-TECH HEALTHCARE PVT LTD ($2.7M). SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED processed 98 shipments from TANZANIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ampicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ampicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED's capped import value divided by total capped export value for Ampicillin across all Indian exporters.
- 5.Verified Records: This page is backed by 98 individual customs records matching SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED importing Ampicillin, covering 57 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 924+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ampicillin Import Data for SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED's Ampicillin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED × Ampicillin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SPARSH BIO-TECH HEALTHCARE PRIVATE LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ampicillin. For current order-level data, contact TransData Nexus.